Lamda Therapeutics is a pre-clinical phase biotech start-up developing innovative approaches for the treatment of obesity, diabetes and related cardiometabolic diseases. It harnesses natural control mechanisms of adipose tissue inflammation that are not targeted by current medication.

Lamda Therapeutics’ approach focuses on the design and engineering of novel compounds and proteins that can restore normality in the adipose tissue and treat patients in need. Identification of patients that are most suitable for such medication is another major direction Lamda Therapeutics is pursuing.

​Vision
Our vision is to improve the treatment of obesity, diabetes and related cardiometabolic disorders by targeting a major disease mechanism that is not affected by existing medication.